BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
May 26, 2010
View Archived Issues
In a challenging environment, the top-quality deals get done
MINNEAPOLIS – With the initial public offering (IPO) window essentially nailed shut over the past two-plus years, corporate buyers have held the keys to the exit for venture-backed companies. (Medical Device Daily)
Read More
Sharfstein acknowledges need to address safety with public
Read More
Doctors embrace innovation in new generation of stents
Read More
Test predicts likelihood of prostate cancer reoccurrence
Read More
Stentys wins CE mark for its self-expanding DES
Read More
MDD's food for med tech thought
Read More
RVO receives $35M funding; Phreesia closes $16M round
Read More
SunTech's blood pressure technology chosen by Damec
Read More
People in the News
Read More
Exactech acquires Brighton in $5.5M all-cash transaction
Read More
Firm investigates Odyssey for possible fiduciary breach
Read More
Product Briefs
Read More
Boston Sci's PTCA catheter gains CE mark, FDA approval
Read More
MDD's Oncology Extra
Read More
